Tags

Type your tag names separated by a space and hit enter

Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist.
Biochem J. 2011 Aug 15; 438(1):111-9.BJ

Abstract

The cholesterol biosynthetic pathway produces not only sterols but also non-sterol mevalonate metabolites involved in isoprenoid synthesis. Mevalonate metabolites affect transcriptional and post-transcriptional events that in turn affect various biological processes including energy metabolism. In the present study, we examine whether mevalonate metabolites activate PPARγ (peroxisome-proliferator-activated receptor γ), a ligand-dependent transcription factor playing a central role in adipocyte differentiation. In the luciferase reporter assay using both GAL4 chimaera and full-length PPARγ systems, a mevalonate metabolite, FPP (farnesyl pyrophosphate), which is the precursor of almost all isoprenoids and is positioned at branch points leading to the synthesis of other longer-chain isoprenoids, activated PPARγ in a dose-dependent manner. FPP induced the in vitro binding of a co-activator, SRC-1 (steroid receptor co-activator-1), to GST (glutathione transferase)-PPARγ. Direct binding of FPP to PPARγ was also indicated by docking simulation studies. Moreover, the addition of FPP up-regulated the mRNA expression levels of PPARγ target genes during adipocyte differentiation induction. In the presence of lovastatin, an HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitor, both intracellular FPP levels and PPARγ-target gene expressions were decreased. In contrast, the increase in intracellular FPP level after the addition of zaragozic acid, a squalene synthase inhibitor, induced PPARγ-target gene expression. The addition of FPP and zaragozic acid promotes lipid accumulation during adipocyte differentiation. These findings indicated that FPP might function as an endogenous PPARγ agonist and regulate gene expression in adipocytes.

Authors+Show Affiliations

Laboratory of Molecular Function of Food, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji 611-0011, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21605082

Citation

Goto, Tsuyoshi, et al. "Farnesyl Pyrophosphate Regulates Adipocyte Functions as an Endogenous PPARγ Agonist." The Biochemical Journal, vol. 438, no. 1, 2011, pp. 111-9.
Goto T, Nagai H, Egawa K, et al. Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem J. 2011;438(1):111-9.
Goto, T., Nagai, H., Egawa, K., Kim, Y. I., Kato, S., Taimatsu, A., Sakamoto, T., Ebisu, S., Hohsaka, T., Miyagawa, H., Murakami, S., Takahashi, N., & Kawada, T. (2011). Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. The Biochemical Journal, 438(1), 111-9. https://doi.org/10.1042/BJ20101939
Goto T, et al. Farnesyl Pyrophosphate Regulates Adipocyte Functions as an Endogenous PPARγ Agonist. Biochem J. 2011 Aug 15;438(1):111-9. PubMed PMID: 21605082.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. AU - Goto,Tsuyoshi, AU - Nagai,Hiroyuki, AU - Egawa,Kahori, AU - Kim,Young-Il, AU - Kato,Sota, AU - Taimatsu,Aki, AU - Sakamoto,Tomoya, AU - Ebisu,Shogo, AU - Hohsaka,Takahiro, AU - Miyagawa,Hiroh, AU - Murakami,Shigeru, AU - Takahashi,Nobuyuki, AU - Kawada,Teruo, PY - 2011/5/25/entrez PY - 2011/5/25/pubmed PY - 2011/10/7/medline SP - 111 EP - 9 JF - The Biochemical journal JO - Biochem J VL - 438 IS - 1 N2 - The cholesterol biosynthetic pathway produces not only sterols but also non-sterol mevalonate metabolites involved in isoprenoid synthesis. Mevalonate metabolites affect transcriptional and post-transcriptional events that in turn affect various biological processes including energy metabolism. In the present study, we examine whether mevalonate metabolites activate PPARγ (peroxisome-proliferator-activated receptor γ), a ligand-dependent transcription factor playing a central role in adipocyte differentiation. In the luciferase reporter assay using both GAL4 chimaera and full-length PPARγ systems, a mevalonate metabolite, FPP (farnesyl pyrophosphate), which is the precursor of almost all isoprenoids and is positioned at branch points leading to the synthesis of other longer-chain isoprenoids, activated PPARγ in a dose-dependent manner. FPP induced the in vitro binding of a co-activator, SRC-1 (steroid receptor co-activator-1), to GST (glutathione transferase)-PPARγ. Direct binding of FPP to PPARγ was also indicated by docking simulation studies. Moreover, the addition of FPP up-regulated the mRNA expression levels of PPARγ target genes during adipocyte differentiation induction. In the presence of lovastatin, an HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitor, both intracellular FPP levels and PPARγ-target gene expressions were decreased. In contrast, the increase in intracellular FPP level after the addition of zaragozic acid, a squalene synthase inhibitor, induced PPARγ-target gene expression. The addition of FPP and zaragozic acid promotes lipid accumulation during adipocyte differentiation. These findings indicated that FPP might function as an endogenous PPARγ agonist and regulate gene expression in adipocytes. SN - 1470-8728 UR - https://www.unboundmedicine.com/medline/citation/21605082/Farnesyl_pyrophosphate_regulates_adipocyte_functions_as_an_endogenous_PPARγ_agonist_ L2 - https://portlandpress.com/biochemj/article-lookup/doi/10.1042/BJ20101939 DB - PRIME DP - Unbound Medicine ER -